PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

New study finds compounds show promise in blocking STAT3 signaling as treatment for osteosarcoma

2011-04-12
(Press-News.org) A study appearing in the journal Investigational New Drugs and conducted by researchers at Nationwide Children's Hospital, discovered that two new small molecule inhibitors are showing promise in blocking STAT3, a protein linked to the most common malignant bone tumor, osteosarcoma. These small molecule inhibitors – one derived from a portion of the turmeric spice – may serve as a new, non-toxic treatment for these deadly tumors.

Osteosarcoma is aggressive and its treatment outlook has not changed significantly over the last 20 years. Treatment consists of a combination of toxic chemotherapy and aggressive surgical resection. Yet, despite these options, patients have at most a 50-to-60 percent five-year disease-free survival rate.

"The outcome for patients with advanced or metastatic osteosarcoma continues to be dismal, emphasizing the need for new therapies," said the study's lead author Jaiyuh Lin, PhD, principal investigator in the Center for Childhood Cancer in The Research Institute at Nationwide Children's Hospital. "Directly targeting STAT3 signaling represents a potential therapeutic approach to treating this type of cancer."

STAT3 is a member of a protein family that plays a role in relaying signals from cytokines and growth factors. The abnormal activation of STAT proteins is becoming more commonly associated with unrestricted cell growth and transformation of normal cells into malignant cells. Abnormal STAT3 activation has been seen in human and canine osteosarcoma cell lines and shows cancer-causing-capabilities in cultured cells and mouse models.

"Recent experiments aimed at blocking STAT3 signaling have been successful, resulting in the inhibition of growth and the induction of death in tumors," said Dr. Lin, also a faculty member at The Ohio State University College of Medicine. "They have also shown that blocking STAT3 in normal cells is neither harmful nor toxic."

Dr. Lin and his team evaluated two newly developed compounds, LLL12 and FLLL32, to determine their ability to inhibit STAT3 activity in human osteosarcoma cells. FLLL32 is derived from the dietary agent curcumin, the principal compound in the popular Indian spice turmeric.

Findings showed that both agents were able to inhibit STAT3 activity and suppressed tumor growth in the mouse model that was developed using human osteosarcoma cells, and primary osteosarcoma xenograft provided by Nationwide Children's Hospital scientist, Peter Houghton, PhD, directly from a patient.

"This study suggests that LLL12 and FLLL32 should be suitable for targeting osteosarcoma and possibly certain types of cancer cells with persistently activated STAT3," said Dr. Lin. "This approach deserves further exploration as a potential treatment of osteosarcoma."

### The development of both STAT3 inhibitors is in the collaboration with Drs. Chenglong Li, Pui-Kai Li and Jim Fuchs from The Ohio State University College of Pharmacy.

Ranked in U.S.News & World Report's 2010 "America's Best Children's Hospitals" and Parents magazine's 2009 top 10 "Best Children's Hospitals" lists, Nationwide Children's Hospital is one of the nation's largest not-for-profit freestanding pediatric healthcare networks providing care for infants, children, adolescents and adult patients with congenital disease. As home to the Department of Pediatrics of The Ohio State University College of Medicine, Nationwide Children's Hospital faculty train the next generation of pediatricians, scientists and pediatric specialists. The Research Institute at Nationwide Children's Hospital is one of the top 10 National Institutes of Health-funded free-standing pediatric research facilities in the U.S., supporting basic, clinical, translational and health services research at Nationwide Children's Hospital. Currently, two buildings totalling approximately 300,000 square feet are dedicated to research on the Nationwide Children's campus. An additional 225,000 square feet of research space will be added when a third research building opens in 2012. More information is available at NationwideChildrens.org/Research.


ELSE PRESS RELEASES FROM THIS DATE:

New sepsis discovery goes straight to the heart to save lives

2011-04-12
New research published online in The FASEB Journal (http://www.fasebj.org) details research in rats and mice that offers hope for stopping the devastating, and often fatal, effects of sepsis in humans. In the study, University of Michigan researchers show how neutralizing the effects of a key protein fragment, called C5a, used by the immune system to attract white blood cells may ultimately prevent heart failure. "During sepsis, heart failure is a common feature of the later stages of the syndrome," said Peter A. Ward, M.D., a senior scientist involved in the work from ...

First clinical trial of gene therapy for pain reported by U-M neurologists

2011-04-12
Ann Arbor, Mich. — In the first clinical trial of gene therapy for treatment of intractable pain, researchers from the University of Michigan Department of Neurology observed that the treatment appears to provide substantial pain relief. In a study published online in the Annals of Neurology last week, the researchers showed that the novel agent NP2 is safe and well-tolerated. In addition, measures of pain in the treated patients suggested that NP2 may provide a substantial analgesic effect. NP2 is a gene transfer vector that expresses the naturally-occurring opioid ...

Tiny antibody fragments raised in camels find drug targets in human breast cancer cells

2011-04-12
A new discovery published online in The FASEB Journal (http://www.fasebj.org) promises to help physicians identify patients most likely to benefit from breast cancer drug therapies. If the compound, called "Nanobody," proves effective in clinical trials, it would represent a significant advance for breast cancer drug therapy because some drugs are effective only in some people. In addition, some drugs have side effects that may cause damage to vital organs, making it more crucial for physicians to get the right treatment to the right patient the first time around. "What ...

Statins may protect against kidney complications following elective surgery

2011-04-12
Taking a statin before having major elective surgery reduces potentially serious kidney complications, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN). Each year, more than 230 million major elective surgeries are performed around the world. Unfortunately, many patients who undergo major operations develop kidney injury soon after surgery, often due to decreased blood flow to the kidneys and/or the effects of inflammation. Animal studies suggest that the cholesterol-lowering drugs called statins protect the ...

Atlanta Shredding Company Shred-Green to Hold Free Shredding Event in Lilburn

2011-04-12
Atlanta shredding company Shred-Green is partnering with Atlanta Recycling Solutions for a free shredding and electronics recycling event on April 16 for residents in Gwinnett and neighboring counties. Shred-Green will be on site to shred documents and collect electronics for recycling. Shred-Green and Atlanta Recycling Solutions will be holding their free Atlanta paper shredding day from 10 a.m. until 2 p.m. on April 16 at Gwinnett Bible Chapel. The chapel is located at 3819 Five Forks Trickum Road in Lilburn. As with all of its free shredding events, Shred-Green ...

Estrogen treatment with no side-effects in sight

2011-04-12
Oestrogen treatment for osteoporosis has often been associated with serious side-effects. Researchers at the Sahlgrenska Academy, University of Gothenburg, Sweden, have now, in mice, found a way of utilising the positive effects of oestrogen in mice so that only the skeleton is acted on, current research at the Academy shows. The study is presented in the respected journal PNAS (Proceedings of the National Academy of Sciences). Many women are affected by osteoporosis after the menopause, when the body's production of oestrogen decreases. Oestrogen is the hormone that ...

New genetic tool helps researchers to analyze cells' most important functions

2011-04-12
Although it has been many years since the human genome was first mapped, there are still many genes whose function we do not understand. Researchers from the University of Gothenburg, Sweden, and the University of Toronto, Canada, have teamed up to produce and characterize a collection of nearly 800 strains of yeast cells that make it possible to study even the most complicated of genes. One common way of studying the role of genes in cells is to remove a gene and investigate the effect of the loss. Genes are very similar in both yeast and people, which is one reason ...

Waited Until the Last Minute to File Taxes? Challenge Blue Tax to Get It Done!!

2011-04-12
Sometimes just when you think you've got it handled, you realize every month you're sinking deeper and deeper. This is how Juan (Freemont, TX) felt when he finally called Blue Tax to assist him with an existing payment plan to the IRS that was proving to be too high for him. When Juan came to Blue Tax, he had an outstanding balance of $3,197 owed to the IRS for his 2007 tax returns. Juan still needed to file his 2008 and 2009 returns, having neglected to do so after being overwhelmed with the debt he still owed. For this 2007 debt, he was on a payment plan of $500 a ...

Antibiotic resistance spreads rapidly between bacteria

Antibiotic resistance spreads rapidly between bacteria
2011-04-12
The part of bacterial DNA that often carries antibiotic resistance is a master at moving between different types of bacteria and adapting to widely differing bacterial species, shows a study made by a research team at the University of Gothenburg in cooperation with Chalmers University of Technology. The results are published in an article in the scientific journal Nature Communications. More and more bacteria are becoming resistant to our common antibiotics, and to make matters worse, more and more are becoming resistant to all known antibiotics. The problem is known ...

New ASPEN Virtual File Room and Virtual Records Center Releases Provide Organizations with Enhanced Business Intelligence Capabilities

2011-04-12
Archive Systems, Inc., a leading provider of records and document management services, today announced ASPEN Virtual File Room, Release 9.9 and ASPEN Virtual Records Center, Release 6.1 during the company's first annual User Conference in Orlando, Florida. The releases incorporate new features and functionality that dramatically enhance the business intelligence capabilities that records managers have available at their fingertips. ASPEN Virtual File Room, Release 9.9, an on-demand document management solution, significantly improves business processes by allowing documents ...

LAST 30 PRESS RELEASES:

Bipolar disorder heterogeneity decoded: transforming global psychiatric treatment approaches

Catching Alport syndrome through universal age-3 urine screening

Instructions help you remember something better than emotions or a good night’s sleep

Solar energy is now the world’s cheapest source of power, a Surrey study finds

Scientists reverse Alzheimer’s in mice using nanoparticles

‘Good’ gut bacteria boosts placenta for healthier pregnancy

USC team demonstrates first optical device based on “optical thermodynamics”

Microplastics found to change gut microbiome in first human-sample study

Artificially sweetened and sugary drinks are both associated with an increased risk of liver disease, study finds

Plastic in the soil, but not as we know it: Biodegradable microplastics rewire carbon storage in farm fields

Yeast proteins reveal the secrets of drought resistance

Psychiatry, primary care, and OB/GYN subspecialties hit hardest by physician attrition

New Canadian study reveals where HIV hides in different parts of the body

Lidocaine poisonings rise despite overall drop in local anesthetic toxicity

Politics follow you on the road

Scientists blaze new path to fighting viral diseases

The mouse eye as a window to spotting systemic disease

AI and the Future of Cancer Research and Cancer Care to headline October 24 gathering of global oncology leaders at the National Press Club: NFCR Global Summit to feature top scientists, entrepreneurs

FDA clears UCLA heart tissue regeneration drug AD-NP1 for clinical trials

Exploring the therapeutic potential of cannabidiol for Alzheimer's

We need a solar sail probe to detect space tornadoes earlier, more accurately, U-M researchers say

Acute myeloid leukemia (AML): Disease risk but not remission status determines transplant outcomes – new ASAP long-term results

Sperm microRNAs: Key regulators of the paternal transmission of exercise capacity

Seeing double: Clever images open doors for brain research

Inhaler-related greenhouse gas emissions in the US

UCLA Health study finds inhalers for asthma and COPD drive significant greenhouse gas emissions

A surgical handover system for patient physiology and safety

Cardiovascular health changes in young adults and risk of later-life cardiovascular disease

Nurse workload and missed nursing care in neonatal intensive care units

How to solve the remote work stalemate – dissertation offers tools for successful hybrid work

[Press-News.org] New study finds compounds show promise in blocking STAT3 signaling as treatment for osteosarcoma